Universität zu Köln

Rubbert-Roth, A., Burmester, G. R., Doerner, T. and Gause, A. (2014). Recommendations for use of rituximab in patients with rheumatoid arthritis. Z. Rheumatol., 73 (2). S. 165 - 174. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1435-1250

Full text not available from this repository.

Abstract

Treatment with rituximab (RTX) has been approved since 2006 for patients with rheumatoid arthritis who previously failed to respond to tumor necrosis factor (TNF) inhibitor therapy or who experienced side effects. In these updated treatment recommendations new data relating to evaluation of the therapeutic response, retreatment, the role of predictive factors as well as safety data are incorporated and discussed.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Rubbert-Roth, A. UNSPECIFIED UNSPECIFIED UNSPECIFIED Burmester, G. R. UNSPECIFIED UNSPECIFIED UNSPECIFIED Doerner, T. UNSPECIFIED UNSPECIFIED UNSPECIFIED Gause, A. UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-444620
DOI:	10.1007/s00393-013-1238-2
Journal or Publication Title:	Z. Rheumatol.
Volume:	73
Number:	2
Page Range:	S. 165 - 174
Date:	2014
Publisher:	SPRINGER HEIDELBERG
Place of Publication:	HEIDELBERG
ISSN:	1435-1250
Language:	German
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language ANTITUMOR NECROSIS FACTOR; B-CELL DEPLETION; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RANDOMIZED CONTROLLED-TRIAL; EULAR RECOMMENDATIONS; CONSENSUS STATEMENT; RECEIVING RITUXIMAB; PLUS METHOTREXATE; JOINT DAMAGE; DOUBLE-BLIND Multiple languages Rheumatology Multiple languages
URI:	http://kups.ub.uni-koeln.de/id/eprint/44462